PMID- 38094127 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240131 IS - 2297-055X (Print) IS - 2297-055X (Electronic) IS - 2297-055X (Linking) VI - 10 DP - 2023 TI - Aging exacerbates cardiac dysfunction and mortality in sepsis through enhancing TLR2 activity. PG - 1293866 LID - 10.3389/fcvm.2023.1293866 [doi] LID - 1293866 AB - INTRODUCTION: Sepsis is prevalent in the elderly population with increased incidence and mortality. Currently, the mechanism by which aging increases the susceptibility to sepsis and worsens outcome is unclear. We tested the hypothesis that aging exacerbates cardiac dysfunction in sepsis through a Toll-like receptor 2 (TLR2)-dependent mechanism. METHODS: Male young adult (4-6 months) and old (18-20 months) wild type (WT) and TLR2 knockout (KO) mice were subject to moderate sepsis by cecal ligation and puncture. Additional groups of young adult and old WT mice were treated with TLR2 agonist Pam3CSK4. Left ventricle (LV) performance was evaluated with a pressure-volume microcatheter. Tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, IL-6 and monocyte chemoattractant protein-1 (MCP-1) in the myocardium and plasma were assessed using enzyme-linked immunosorbent assay. RESULTS: Sepsis reduced LV ejection fraction and cardiac output in both young adult and old WT mice. However, identical CLP caused more severe cardiac dysfunction and high mortality in old WT mice that were accompanied by greater levels of TNF-alpha, IL-1beta, IL-6 and MCP-1 in the myocardium and plasma. TLR2 KO diminished aging-related difference in myocardial and systemic inflammatory response, resulting in improved cardiac function and decreased mortality in old septic mice. In addition, higher myocardial TLR2 levels in old WT mice resulted in greater myocardial inflammatory response and worse cardiac dysfunction following administration of TLR2 agonist. CONCLUSION: Moderate sepsis results in greater cardiac dysfunction and significant mortality in old mice. Aging elevates TLR2 level/activity to exacerbate the inflammatory response to sepsis, leading to worse cardiac dysfunction and mortality. CI - (c) 2023 Zhai, Yao, The, Ao, Fullerton and Meng. FAU - Zhai, Yufeng AU - Zhai Y AD - Department of Surgery, University of Colorado Denver, Aurora, CO, United States. FAU - Yao, Qingzhou AU - Yao Q AD - Department of Surgery, University of Colorado Denver, Aurora, CO, United States. FAU - The, Erlinda AU - The E AD - Department of Surgery, University of Colorado Denver, Aurora, CO, United States. FAU - Ao, Lihua AU - Ao L AD - Department of Surgery, University of Colorado Denver, Aurora, CO, United States. FAU - Fullerton, David A AU - Fullerton DA AD - Department of Surgery, University of Colorado Denver, Aurora, CO, United States. FAU - Meng, Xianzhong AU - Meng X AD - Department of Surgery, University of Colorado Denver, Aurora, CO, United States. LA - eng GR - R01 GM129641/GM/NIGMS NIH HHS/United States PT - Journal Article DEP - 20231129 PL - Switzerland TA - Front Cardiovasc Med JT - Frontiers in cardiovascular medicine JID - 101653388 PMC - PMC10716470 OTO - NOTNLM OT - aging OT - cardiac dysfunction OT - mortality OT - myocardial TLR2 OT - sepsis COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/12/14 06:42 MHDA- 2023/12/14 06:43 PMCR- 2023/01/01 CRDT- 2023/12/14 04:10 PHST- 2023/09/18 00:00 [received] PHST- 2023/11/14 00:00 [accepted] PHST- 2023/12/14 06:43 [medline] PHST- 2023/12/14 06:42 [pubmed] PHST- 2023/12/14 04:10 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fcvm.2023.1293866 [doi] PST - epublish SO - Front Cardiovasc Med. 2023 Nov 29;10:1293866. doi: 10.3389/fcvm.2023.1293866. eCollection 2023.